PharmTech LCGC Sciex Webinar 11.10
|Articles|July 7, 2010

Microsoft Life Sciences Innovation award

Thermo Fisher Scientific announced that it has been awarded the Microsoft Life Sciences Innovation Award for the third consecutive year.

Thermo Fisher Scientific announced that it has been awarded the Microsoft Life Sciences Innovation Award for the third consecutive year. The award recognizes companies for their innovative use of Microsoft-based solutions.

The company was selected together with Emory University, part of the Atlantic Clinical and Translational Science Institute (ACTSI), for the use of LIMS to advance information exchange in the clinical and translational science environment across a diverse set of laboratories.

Michael Naimoli, director of life sciences industry solutions, Microsoft explained more: “The Emory/ACTSI implementation takes advantage of Thermo Scientific WebAccess deployed on Microsoft technologies to deliver rich client functionality via a web browser to both internal and external users. In addition, the Study Design Module created by Thermo Fisher and Emory using Microsoft tools provides an easy to use graphical user interface for study design, which allows the ACTSI to design workflows more quickly.”

The institute is focused on accelerating the translation of laboratory discoveries into healthcare innovations for patients and plays an important role in North American health research by supporting investigators across Emory University, Morehouse School of Medicine, Grady Hospital, Children’s Healthcare of Atlanta and the Georgia Institute of Technology. A key initiative is the selection and deployment of LIMS across the consortium to support a “virtual bio-repository” environment.

For more information visit www.thermoscientific.com/awards


Related to this article

Best of the Week: From Cancer Diagnostics to Smarter LC Method Development
This week, Chromatography Online’s coverage spanned lipidomics-based early cancer detection, career paths in separation science, machine learning and uncertainty-driven approaches to LC method development, new EU wastewater rules for pharmaceutical micropollutants, automated Separation Quality Factor (SQF) evaluation in chromatography data systems, and solutions to GLP-1 peptide analysis challenges.